MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
31.25
+1.30
+4.34%
After Hours: 32.00 +0.75 +2.40% 16:29 05/12 EDT
OPEN
30.00
PREV CLOSE
29.95
HIGH
31.47
LOW
29.40
VOLUME
321.67K
TURNOVER
--
52 WEEK HIGH
31.65
52 WEEK LOW
14.59
MARKET CAP
2.16B
P/E (TTM)
-8.9649
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris Extends Cash Runway Into 2028 as Deucrictibant Nears Key Late-Stage Milestones
TipRanks · 18m ago
Switzerland's Pharvaris Q1 loss per share narrows
Reuters · 30m ago
Pharvaris Raises $124 Million in May Equity Offering to Fund Late-Stage Programs and U.S. Commercial Build-Out
TipRanks · 23h ago
Pharvaris Chief Medical Officer Sells 14,000 Shares for $427,000
The Motley Fool · 1d ago
Pharvaris closes follow-on offering, raises $132.3 million gross proceeds
PUBT · 1d ago
Pharvaris Reports Earnings Days After Pricing a Hundred Million Dollar Offering
Barchart · 1d ago
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Barchart · 1d ago
Weekly Report: what happened at PHVS last week (0504-0508)?
Weekly Report · 1d ago
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.